RxDoctor Payments Data

John Bailey, DO

Orthopaedic Surgery of the Spine · Kirksville, MONPI 1063415354

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in MO, where the typical reported total is $12,644.

$527in general payments, 2019–2025

Across 28 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elite Orthopedics, LLC$119
  • Stryker$92
  • Kowa Pharmaceuticals America, Inc.$91
  • Augmedics Inc.$51
  • Globus Medical$40
  • Smith+Nephew$35
  • plus $98 from 4 others

What the payments were for

  • Food & beverage$527100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$527 in reported general payments places this provider in the 15th percentile of 53 orthopaedic surgery of the spine providers in Missouri.

See all orthopaedic surgery of the spine providers in Missouri

Medicare billing

Part B allowed, 2024
$151,286
Medicare patients
260
Services billed
1,398

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
HorizantGabapentin Enacarbil32$35,457
OxycontinOxycodone Hcl34$22,585
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen580$21,086
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen524$19,671
Oxymorphone Hcl ErOxymorphone Hcl22$14,670
Fentanyl73$9,016
Oxycodone Hcl334$8,701
Xtampza ErOxycodone Myristate11$7,724
Morphine Sulfate ErMorphine Sulfate247$7,670
LyricaPregabalin11$4,861
Hysingla ErHydrocodone Bitartrate12$4,190
Hydromorphone Hcl209$3,413
MovantikNaloxegol Oxalate12$3,169
Methylprednisolone316$2,772
Pregabalin110$2,581

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerLyrica$24$4,86111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 53 orthopaedic surgery of the spine providers in Missouri.

Other orthopaedic surgery of the spine in Kirksville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →